Error: Could not add to watchlist. X

Puma Biotechnology Inc

+ Watchlist
PBYI:US
New York
112.11
USD
0.15
0.13%
As of 20:04:04 ET on 07/03/2015.
Open
112.61
Day Range
111.12 - 113.80
Volume
672,627
Previous Close
112.26
52Wk Range
57.25 - 279.37
1 Yr Return
60.16%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.71
Market Cap (b USD)
3.604
Shares Outstanding (m)
32.151
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Puma Biotechnology, Inc. is a development-stage biopharmaceutical company. The Company develops novel therapeutics for the treatment of various forms of cancer. Puma focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use.
ADDRESS
10880 Wilshire Blvd, Suite 215
Los Angeles, CA 90024
United States
PHONE
1-425-248-6500
  • Alan H Auerbach
    Chairman/President/CEO/Founder
  • Richard P Bryce
    Senior VP:Clinical Rsch & Dev
  • Charles R Eyler
    Senior VP:Finance & Administration
  • Erin A Jones
    VP:Global Regulatory Affairs
Show More